Linkage Newsletter - DCEG News Updates
Longer-format articles that go in-depth on DCEG research or profile investigators. These articles are distributed three times each year as the DCEG Newsletter, Linkage.
-
Progress Assessing Cancer Risk Using Clinical Practice Research Datalink
DCEG scientists use data from the Clinical Practice Research Datalink to investigate risk factors and exposures that may contribute to cancer risk, ranging from medication usage to genetic cancer predisposition.
-
Understanding the Role of Physical Activity, Obesity, and Diet in Cancer: Profile of Tenure-track Investigator Steven Moore
Tenure-track investigator, Steven C. Moore, Ph.D., M.P.H, has built a multidisciplinary research program in the Metabolic Epidemiology Branch focused on understanding the contributions of physical activity, obesity, and diet to human cancer and overall health.
-
Elizabeth Platz Delivers Seminar on Trans-Disciplinary Epidemiology Research on Prostate Cancer
Elizabeth Platz, Sc.D., Deputy Chair of the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health, spent two days at DCEG as a Visiting Scholar in December 2019. Learn more about her visit.
-
Lindsay Morton Appointed Deputy Chief of the Radiation Epidemiology Branch
Lindsay Morton, Ph.D., has been appointed Deputy Chief of the Radiation Epidemiology Branch as of January 7, 2020.
-
Martha Linet Retires from DCEG after 33 Years of Service to the NCI
Martha Linet, M.D., M.P.H., Senior Investigator and former Branch Chief in the Radiation Epidemiology Branch (REB), retired in January 2020 after 33 years of service to the National Cancer Institute.
-
Ruth Kleinerman Retires From DCEG
Ruth A. Kleinerman, Ph.D., M.P.H., staff scientist and deputy chief in the Radiation Epidemiology Branch (REB) will retire at the end of 2019 after 40 years of service. Dr. Kleinerman is widely recognized for her work on treatment-related second cancers.
-
Mark Greene Retires From DCEG
Mark H. Greene, M.D., senior principal investigator in the Clinical Genetics Branch retires from the National Cancer Institute after 33 years of distinguished service.
-
Mitchell Gail and Robert Hoover Named NIH Distinguished Investigators
Mitchell H. Gail, M.D., Ph.D., and Robert N. Hoover, M.D., D.Sc., have been named NIH Distinguished Investigators in recognition of career achievements and impact on their respective scientific fields.
-
2020 Sallie Rosen Kaplan Fellowship Recipients and Diversity Career Development Program Selections
Rebecca Hennessey and Daphnée Villoing received the 2020 Sallie Rosen Kaplan Fellowship. Rotana Alsaggaf, Marena Niewisch, and Christian Alvarez Privado selected for 2020 Diversity Career Development Program.
-
NIH-AARP Diet and Health Study Reaches Milestone
Nearly 25 years ago, NCI investigators mailed over three million members of the AARP a food frequency questionnaire to examine the relationship between diet, lifestyle, and cancer risk among older Americans. With the response of over half a million people, the NCI launched the NIH-AARP Diet and Health Study, a cohort that was, and remains, the largest prospective in-depth study on diet and health.
-
Molecular and Digital Pathology Laboratory Expands Capacity for DCEG Studies
The Molecular and Digital Pathology Laboratory is an extension of the Cancer Genomics Research Laboratory that integrates histological and molecular tissue profiling with analyses of environmental and genetic risk factors in epidemiologic studies.
-
Clarice Weinberg Delivers 2019 Wacholder Lecture
Clarice Weinberg delivered the 2019 Sholom Wacholder Distinguished Lecture on Evidence for Familial Clustering of Breast Cancer Age at Onset.
-
Sir John Burn Delivers Seminar on Prediction and Prevention of Colorectal Cancer in Patients with Lynch Syndrome
In July 2019, Sir John Burn spent two days with DCEG staff and fellows as a Visiting Scholar during which time he delivered an informative seminar on prediction and prevention of colorectal cancer in patients with Lynch Syndrome.
-
The Unique Role of Staff Clinicians in DCEG Research
Staff clinicians operate at the intersection of clinical care and research on natural history studies of families with cancer predisposition syndromes like Inherited Bone Marrow Failure (IBMFS) and Li-Fraumeni Syndrome (LFS).
-
Laboratory of Translational Genomics Celebrates 10th Anniversary with Symposium
In December 2018, DCEG hosted a day-long symposium in celebration of the 10th anniversary of the founding of the Laboratory of Translational Genomics (LTG). The symposium highlighted the history and key discoveries of the LTG and its investigators.
-
Controlling Cervical Cancer: DCEG’s Ongoing Commitment to Improving Women’s Health
Scientists in DCEG are among the leaders of a growing global effort to greatly reduce deaths from cervical cancer
-
Understanding the Etiology of Gynecologic Cancers: Profile of Tenure-Track Investigator Britton Trabert
Tenure-track investigator Britton Trabert, Ph.D., M.S., studies the epidemiology of ovarian cancer and the hormonal etiology of gynecologic cancers.
-
Metabolomics: The Growing Potential of an Emerging Field
DCEG scientists have been evaluating the performance of metabolomics assays and applying them to studies of cancer etiology.
-
Agricultural Exposures, Multiple Myeloma Etiology: Profile of Tenure-track Investigator Jonathan Hofmann
Tenure-track investigator Jonathan Hofmann, Ph.D., M.P.H., has established a research program in the Occupational and Environmental Epidemiology Branch focused on the role of agricultural exposures in the etiology of multiple myeloma and other cancers, and on understanding the biological mechanisms that influence the development and progression of multiple myeloma.
-
Death Before Old Age: Untangling Premature Mortality in the U.S.
DCEG scientists are spearheading the Premature Mortality Project—an interdisciplinary, multi-institutional effort to characterize U.S. trends in premature mortality. In the process, the team has uncovered distinct mortality trends by race, ethnicity, age, and region, and provided crucial information about the ongoing, well-publicized, drug overdose epidemic.